estradiol, 10 mcg

DRUG4 trials

Sponsors

Novo Nordisk A/S

Conditions

MenopausePostmenopausal Vaginal Atrophy

Phase 1

Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis

CompletedNCT01486979

Novo Nordisk A/SMenopause, Postmenopausal Vaginal Atrophy

Start: 2007-01-31End: 2007-05-31Updated: 2017-02-08

Phase 3

Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms

CompletedNCT00108849

Novo Nordisk A/SMenopause, Postmenopausal Vaginal Atrophy

Start: 2005-03-31End: 2007-05-31Updated: 2017-02-08

Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis

CompletedNCT00431132

Novo Nordisk A/SMenopause, Postmenopausal Vaginal Atrophy

Start: 2007-01-31End: 2008-11-30Updated: 2017-03-15

Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis

CompletedNCT00465192

Novo Nordisk A/SMenopause, Postmenopausal Vaginal Atrophy

Start: 1994-08-31End: 1995-11-30Target: 230Updated: 2017-03-01

Related Papers

Does age at the start of treatment for vaginal atrophy predict response to vaginal estrogen therapy? Post hoc analysis of data from a randomized clinical trial involving 205 women treated with 10 μg estradiol vaginal tablets

Menopause The Journal of The North American Menopause Society2020-10-0517 citations

Endometrial safety of ultra-low-dose estradiol vaginal tablets.

2010-10-0150 citations

Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet.

2008-11-01113 citations

Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.

2008-01-01114 citations